SuperworthOncolytics Biotech market cap ONCY
Share price times shares outstanding: what the whole company sells for, since 2018.
- Today, Oct 23, 2026
- $64M
- Highest close in our data
- $1.1B
- May 2018
Oncolytics Biotech is worth $64M at the close on Oct 23, 2026, at $0.50 a share.
That is down 33% over the last year and down 32% over five years.
Its highest close in our data was $1.1B in May 2018.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $64M | $63.5M | $130.1M | −16% |
| 2025 | $76.2M | $27.2M | $110.4M | +3% |
| 2024 | $74M | $60.5M | $100.5M | −11% |
| 2023 | $82.8M | $70.5M | $187.7M | −8% |
| 2022 | $89.7M | $53.9M | $107.3M | +40% |
| 2021 | $64.2M | $64.2M | $185.1M | −16% |
| 2020 | $76.6M | $35.1M | $129.8M | +55% |
| 2019 | $49.4M | $7.5M | $312M | −81% |
| 2018 | $253.8M | $253.8M | $1.1B | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Oncolytics Biotech's size, closest first, today.
| Company | Market cap |
|---|---|
| ONCYOncolytics Biotech | $64M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| ATNMActinium Pharmaceuticals | $47.8M |
| NATRNatures Sunshine Products | $213.8M |
| ARVNArvinas | $477.3M |
| PBYIPuma Biotechnology | $568.9M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| ZVRAZevra Therapeutics | $582.6M |
| CRMDCorMedix | $611.9M |
| Peer median | $477.3M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Oncolytics Biotech
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.